Expression of the lysyl oxidase propeptide in hepatocellular carcinoma and its clinical relevance

Oncology Reports

Volumn 31, Issue 4, 2014, Pages 1669-1676

  Zheng, Ying ^a   Wang, Xuemei ^b   Wang, Haidong ^a   Yan, Wei ^a   Zhang, Quan ^a   Chang, Xin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b OBSTETRICS AND GYNECOLOGY HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Extracellular signal regulated kinase; Growth; Hepatocellular carcinoma; Lysyl oxidase propeptide; Migration

Indexed keywords

CYCLIN D1; CYCLIN E; GELATINASE A; GELATINASE B; KI 67 ANTIGEN; LYSYL OXIDASE PROPEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN LYSINE 6 OXIDASE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER STAGING; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; AGED; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTEIN-LYSINE 6-OXIDASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84908119474     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3044     Document Type: Article

References (36)

1. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
2. Hsu HC, Huang AM, Lai PL, et al: Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma. Hepatology 19: 122-128, 1994.
3. Hsu HC, Jeng YM, Mao TL, et al: β-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am J Pathol 157: 763-770, 2000.
4. Yuan JM, Govindarajan S, Ross RK, et al: Chronic infection with hepatitis G virus in relation to hepatocellular carcinoma among non-Asians in Los Angeles County, California. Cancer 86: 936-943, 1999.
5. Kagan HM and Trackman PC: Properties and function of lysyl oxidase. Am J Respir Cell Mol Biol 5: 206-210, 1991.
6. Kim YM, Kim EC and Kim Y: The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin. Mol Biol Rep 38: 145-149, 2011.
7. Bais MV, Nugent MA, Stephens DN, et al: Recombinant lysyl oxidase propeptide protein inhibits growth and promotes apoptosis of pre-existing murine breast cancer xenografts. PLoS One 7: e31188, 2012.
8. Palamakumbura AH, Vora SR, Nugent MA, et al: Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling. Oncogene 28: 3390-3400, 2009.
9. Hurtado PA, Vora S, Sume SS, et al: Lysyl oxidase propeptide inhibits smooth muscle cell signaling and proliferation. Biochem Biophys Res Commun 366: 156-161, 2008.
10. Min C, Kirsch KH, Zhao Y, et al: The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. Cancer Res 67: 1105-1112, 2007.
11. Palamakumbura AH, Jeay S, Guo Y, et al: The propeptide domain of lysyl oxidase induces phenotypic reversion of ras-transformed cells. J Biol Chem 279: 40593-40600, 2004.
12. Min C, Zhao Y, Romagnoli M, et al: Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis. J Cell Biochem 111: 1160-1168, 2010.
13. Barker HE, Cox TR and Erler JT: The rationale for targeting the LOX family in cancer. Nat Rev Cancer 12: 540-552, 2012.
14. Edmondson HA and Steiner PE: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7: 462-503, 1954.
15. Yang YH, Chen K, Li B, et al: Estradiol inhibits osteoblast apoptosis via promotion of autophagy through the ER-ERK-mTOR pathway. Apoptosis 18: 1363-1375, 2013.
16. Chiu CC, Lin CH and Fang K: Etoposide (VP-16) sensitizes p53-deficient human non-small cell lung cancer cells to caspase-7-mediated apoptosis. Apoptosis 10: 643-650, 2005.
17. Novello C, Pazzaglia L, Cingolani C, et al: miRNA expression profile in human osteosarcoma: Role of miR-1 and miR-133b in proliferation and cell cycle control. Int J Oncol 42: 667-675, 2013.
18. Aigelsreiter A, Ress AL, Bettermann K, et al: Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma. Br J Cancer 108: 1830-1837, 2013.
19. Li B, Yang Y, Jiang S, et al: Adenovirus-mediated overexpression of BMP-9 inhibits human osteosarcoma cell growth and migration through downregulation of the PI3K/AKT pathway. Int J Oncol 41: 1809-1819, 2012.
20. Liu ZL, Wang G, Peng AF, et al: Fatty acid synthase expression in osteosarcoma and its correlation with pulmonary metastasis. Oncol Lett 4: 878-882, 2012.
21. Thompson L, Wang S, Tawfik O, et al: Effect of 25-hydroxyvitamin D 3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines. J Orthop Res 30: 831-844, 2012.
22. Kamei S, Sakayama K, Tamashiro S, et al: Ketoprofen in topical formulation decreases the matrix metalloproteinase-2 expression and pulmonary metastatic incidence in nude mice with osteosarcoma. J Orthop Res 27: 909-915, 2009.
23. Korpi JT, Hagstrom J, Lehtonen N, et al: Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma. Surg Oncol 20: e18-22, 2011.
24. Zhang Y, Song L, Cai L, et al: Effects of baicalein on apoptosis, cell cycle arrest, migration and invasion of osteosarcoma cells. Food Chem Toxicol 53C: 325-333, 2012.
25. Gu X, Xing L, Shi G, et al: The circadian mutation PER2S662G is linked to cell cycle progression and tumorigenesis. Cell Death Differ 19: 397-405, 2012.
26. Oka K, Ohya-Shimada W, Mizuno S, et al: Up-regulation of cyclin-E1 via proline-mTOR pathway is responsible for HGF-mediated G1/S progression in the primary culture of rat hepatocytes. Biochem Biophys Res Commun 435: 120-125, 2013.
27. Rasmussen N and Rathmell WK: Looking beyond inhibition of VEGF/mTOR: emerging targets for renal cell carcinoma drug development. Curr Clin Pharmacol 6: 199-206, 2011.
28. Van Waes C: Nuclear factor-κB in development, prevention, and therapy of cancer. Clin Cancer Res 13: 1076-1082, 2007.
29. Peng L, Liu A, Shen Y, et al: Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway. Oncol Rep 29: 571-578, 2013.
30. Jeng YM, Chang CC, Hu FC, et al: RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. Hepatology 48: 1118-1127, 2008.
31. Chen YL, Wang TH, Hsu HC, et al: Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis. PLoS One 8: e70324, 2013.
32. Sanchez-Morgan N, Kirsch KH, Trackman PC, et al: The lysyl oxidase propeptide interacts with the receptor-type protein tyrosine phosphatase kappa and inhibits β-catenin transcriptional activity in lung cancer cells. Mol Cell Biol 31: 3286-3297, 2011.
33. Yoon JH, Park JK, Kang YH, et al: Lysyl oxidase G473A polymorphism is closely associated with susceptibility to gastric cancer in a South Korean population. APMIS 119: 762-768, 2011.
34. Yu Z, Sato S, Trackman PC, et al: Blimp1 activation by AP-1 in human lung cancer cells promotes a migratory phenotype and is inhibited by the lysyl oxidase propeptide. PLoS One 7: e33287, 2012.
35. Barcellos-Hoff MH and Ravani SA: Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res 60: 1254-1260, 2000.
36. Wiseman BS and Werb Z: Stromal effects on mammary gland development and breast cancer. Science 296: 1046-1049, 2002.